These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34296292)

  • 1. Progression of melanoma is suppressed by targeting all transforming growth factor‑β isoforms with an Fc chimeric receptor.
    Kodama S; Podyma-Inoue KΑ; Uchihashi T; Kurioka K; Takahashi H; Sugauchi A; Takahashi K; Inubushi T; Kogo M; Tanaka S; Watabe T
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
    Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
    J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks.
    Tokizaki S; Podyma-Inoue KA; Matsumoto T; Takahashi K; Kobayashi M; Ibi H; Uchida S; Iwabuchi S; Harada H; Hashimoto S; Miyazono K; Shirouzu M; Watabe T
    Cancer Sci; 2024 Jan; 115(1):211-226. PubMed ID: 37972575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism.
    Canè S; Van Snick J; Uyttenhove C; Pilotte L; Van den Eynde BJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.
    Hachim MY; Hachim IY; Dai M; Ali S; Lebrun JJ
    Tumour Biol; 2018 Jan; 40(1):1010428317748254. PubMed ID: 29320969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer.
    Nilsson E; Doraiswamy V; Parrott JA; Skinner MK
    Mol Cell Endocrinol; 2001 Sep; 182(2):145-55. PubMed ID: 11514049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of in situ and plasma levels of transforming growth factor β1, -2 and -3 in cutaneous melanoma.
    Tang MR; Wang YX; Guo S; Han SY; Li HH; Jin SF
    Mol Med Rep; 2015 Jun; 11(6):4508-12. PubMed ID: 25625662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor.
    De Crescenzo G; Hinck CS; Shu Z; Zúñiga J; Yang J; Tang Y; Baardsnes J; Mendoza V; Sun L; López-Casillas F; O'Connor-McCourt M; Hinck AP
    J Mol Biol; 2006 Jan; 355(1):47-62. PubMed ID: 16300789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction.
    McLean S; Bhattacharya M; Di Guglielmo GM
    Cell Signal; 2013 Jan; 25(1):319-31. PubMed ID: 23069267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts.
    Velasco S; Alvarez-Muñoz P; Pericacho M; Dijke PT; Bernabéu C; López-Novoa JM; Rodríguez-Barbero A
    J Cell Sci; 2008 Mar; 121(Pt 6):913-9. PubMed ID: 18303046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFβ1-Smad Signaling Pathway Participates in Interleukin-33 Induced Epithelial-to-Mesenchymal Transition of A549 Cells.
    Tan QY; Cheng ZS
    Cell Physiol Biochem; 2018; 50(2):757-767. PubMed ID: 30308508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2 Modulates the TGFβ/Smad, TGFβ/ERK and Notch Signaling Pathways in Human Lens Epithelial-Mesenchymal Transition.
    Hou M; Bao X; Luo F; Chen X; Liu L; Wu M
    Curr Mol Med; 2018; 18(2):71-82. PubMed ID: 29974827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-dependent epithelial-mesenchymal transition of tumor cells: exclusive roles of transforming growth factor β1 and β2.
    Kimura C; Hayashi M; Mizuno Y; Oike M
    Biochim Biophys Acta; 2013 Oct; 1830(10):4470-81. PubMed ID: 23668958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric extracellular domain type II transforming growth factor (TGF)-beta receptor fused to the Fc region of human immunoglobulin as a TGF-beta antagonist.
    Komesli S; Vivien D; Dutartre P
    Eur J Biochem; 1998 Jun; 254(3):505-13. PubMed ID: 9688260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial-mesenchymal transition of cancer cells.
    Lam CR; Tan C; Teo Z; Tay CY; Phua T; Wu YL; Cai PQ; Tan LP; Chen X; Zhu P; Tan NS
    Cell Death Dis; 2013 Oct; 4(10):e848. PubMed ID: 24113182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
    Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
    Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference of TGF-β/Smads signaling pathway in epithelial-mesenchymal transition of normal colonic epithelial cells induced by tumor-associated fibroblasts and colon cancer cells.
    Wang XL; Huang C
    Mol Biol Rep; 2019 Jun; 46(3):2749-2759. PubMed ID: 30835040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II.
    Jacko AM; Nan L; Li S; Tan J; Zhao J; Kass DJ; Zhao Y
    Cell Death Dis; 2016 Nov; 7(11):e2474. PubMed ID: 27853171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.
    Wehbe M; Soudja SM; Mas A; Chasson L; Guinamard R; de Tenbossche CP; Verdeil G; Van den Eynde B; Schmitt-Verhulst AM
    PLoS One; 2012; 7(11):e49419. PubMed ID: 23173060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.